News | May 19, 2023
KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
The facility will have a capacity to manufacture upto 3 million tubes monthly
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Subscribe To Our Newsletter & Stay Updated
